SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tara Cobble who wrote (44)7/23/1996 8:49:00 AM
From: Joseph wang   of 1154
 
Okay read this FIRST (before reading the last message):

GENE is trading at a PE of 23. last quarter's earnings were 4 cents
compared with a loss of 4 cents in the same period in 1995.

Next quarter's expectations are 6 cents. EPS 1996 (I think) is 32cents.

I believe the company has earnings growth of about 50% from 1996-1997.

So the stock is trading at a reasonable PE...considering others in
the same group do not have a PE (HGSI is trading at PE of 40; INCY is
trading at a PE of 30 based on 1997's EPS).

I think the stock needs to post 6-9 cents in September for the
stock to rise above $10/share.

-JW
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext